Skip to main content
. Author manuscript; available in PMC: 2015 Jun 26.
Published in final edited form as: Acta Neuropathol. 2015 Feb 28;129(4):597–607. doi: 10.1007/s00401-015-1403-6

Fig. 3.

Fig. 3

Sequential acquisition of DNA repair deficiency exclusively in LGG patients that were treated with TMZ and had a hypermutated recurrence. a Exome derived copy number status and germ-line variant allele frequency across chromosome 2 encompassing MSH2 and MSH6 in the initial and recurrent tumor of patient 18. b Methylation level of MGMT, mutations and copy number status of MGMT and MMR-related genes in initial LGG and paired recurrent tumors. The panel includes patients for whom exome sequencing data was available, * indicates samples with a proportion of tumor cells lower than 50%.